secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001824293-24-000094
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio increases ATM offering capacity to $2.64M, reports $961K already sold
-----------------------------------------------------------------------------

- Maximum aggregate gross proceeds from ATM offering raised to $2,644,609 via prospectus supplement filed July 26, 2024.
- Approximately $961,272 of shares have already been sold under the May 20, 2024 Sales Agreement with H.C. Wainwright & Co.
- Shares are common stock, par value $0.0001 per share; proceeds used for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/0001824293-24-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/val-20240726.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer